Citation(s)
- Bartley GB, Gorman CA
Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol. 1995 Jun;119(6):792-5. Review.
- Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M
Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3249-55.
- Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB
A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 2001 Sep;108(9):1523-34. Erratum in: Ophthalmology. 2004 Jul;111(7):1306.
- Guy JR, Fagien S, Donovan JP, Rubin ML
Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy. Ophthalmology. 1989 Jul;96(7):1048-52; discussion 1052-3.
- Hiromatsu Y, Tanaka K, Sato M, Kuroki T, Nonaka K, Kojima K, Nishimura H, Nishida H, Kaise N
Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy. Endocr J. 1993 Feb;40(1):63-72.
- Kao SC, Kendler DL, Nugent RA, Adler JS, Rootman J
Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes. Arch Ophthalmol. 1993 Jun;111(6):819-23.
- Kendall-Taylor P, Crombie AL, Stephenson AM, Hardwick M, Hall K
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. BMJ. 1988 Dec 17;297(6663):1574-8.
- Koshiyama H, Koh T, Fujiwara K, Hayakawa K, Shimbo S, Misaki T
Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation. Thyroid. 1994 Winter;4(4):409-13.
- Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab. 2001 Aug;86(8):3562-7.
- Mourits MP, Prummel MF, Wiersinga WM, Koornneef L
Measuring eye movements in Graves ophthalmopathy. Ophthalmology. 1994 Aug;101(8):1341-6.
- Nagayama Y, Izumi M, Kiriyama T, Yokoyama N, Morita S, Kakezono F, Ohtakara S, Morimoto I, Okamoto S, Nagataki S
Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy. Acta Endocrinol (Copenh). 1987 Dec;116(4):513-8.
- Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, Graeb DA
Graves orbitopathy: correlation of CT and clinical findings. Radiology. 1990 Dec;177(3):675-82.
- Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM
The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy. Clin Endocrinol (Oxf). 2001 Feb;54(2):205-9.
- Smith JR, Rosenbaum JT
A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol. 2001 Oct;85(10):1220-4.
- Tagami T, Tanaka K, Sugawa H, Nakamura H, Miyoshi Y, Mori T, Nakao K
High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy. Endocr J. 1996 Dec;43(6):689-99.
- Van Dyk HJ
Orbital Graves' disease. A modification of the "NO SPECS" classification. Ophthalmology. 1981 Jun;88(6):479-83.
- Warwar RE
New insights into pathogenesis and potential therapeutic options for Graves orbitopathy. Curr Opin Ophthalmol. 1999 Oct;10(5):358-61. Review.
- Werner SC
Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol. 1977 May;83(5):725-7.
Comparison of Efficacy and Safety of Intravenous Pulsed Methylprednisolone and Oral Methotrexate Versus Intravenous Pulsed Methylprednisolone and Oral Placebo in the Treatment of Active Moderate and Severe Thyroid Eye Disease - a Prospective, Randomized, Double-blind, Parallel, Controlled Multidisciplinary Clinical Trial and Imaging Study.
Details for clinical trial NCT00348413
